- The Neuroprotective Effects of Astragaloside IV against H2O2-Induced Damage in SH-SY5Y Cells are Associated with Synaptic Plasticity
Zurong Song et al, 2020, Journal of Chemistry CrossRef - Compatibility of Tanshinone IIA and Astragaloside IV in attenuating hypoxia-induced cardiomyocytes injury
Dawei Wang et al, 2017, Journal of Ethnopharmacology CrossRef - Phytochemistry and cardiovascular protective effects of Huang‐Qi (Astragali Radix)
Hui‐fei Su et al, 2021, Medicinal Research Reviews CrossRef - Astragaloside IV reverses simvastatin‐induced skeletal muscle injury by activating the AMPK‐PGC‐1α signalling pathway
Bing Jiang et al, 2020, Phytotherapy Research CrossRef - Integrated therapy decreases the mortality of patients with polymyositis and dermatomyositis: A Taiwan-wide population-based retrospective study
Ching-Mao Chang et al, 2019, Journal of Ethnopharmacology CrossRef - Astragaloside IV protects cardiomyocytes from anoxia/reoxygenation injury by upregulating the expression of Hes1 protein
Huang Huang et al, 2016, Canadian Journal of Physiology and Pharmacology CrossRef - Astragaloside IV attenuates apoptosis of hypertrophic cardiomyocyte through inhibiting oxidative stress and calpain-1 activation
Meng Mei et al, 2015, Environmental Toxicology and Pharmacology CrossRef - Role of Chinese Herbal Medicines in Regulation of Energy Metabolism in Treating Cardiovascular Diseases
Jie Li et al, 2019, Chinese Journal of Integrative Medicine CrossRef - The inhibitory role of Chinese materia medica in cardiomyocyte apoptosis and underlying molecular mechanism
YuZhen Li et al, 2019, Biomedicine & Pharmacotherapy CrossRef - Baoyuan decoction ameliorates apoptosis via AT1-CARP signaling pathway in H9C2 cells and heart failure post-acute myocardial infarction rats
Xiaoping Wang et al, 2020, Journal of Ethnopharmacology CrossRef - Cardiotoxicity of doxorubicin-based cancer treatment: What is the protective cognition that phytochemicals provide us?
Cun Liu et al, 2020, Pharmacological Research CrossRef - Astragaloside IV-targeting miRNA-1 attenuates lipopolysaccharide-induced cardiac dysfunction in rats through inhibition of apoptosis and autophagy
Qiuning Wang et al, 2021, Life Sciences CrossRef - Integrative therapy decreases the risk of lupus nephritis in patients with systemic lupus erythematosus: A population-based retrospective cohort study
Ching-Mao Chang et al, 2017, Journal of Ethnopharmacology CrossRef - Roles of Chinese herbal medicines in ischemic heart diseases (IHD) by regulating oxidative stress
Dawei Wang et al, 2016, International Journal of Cardiology CrossRef - Evaluation of the effect of Shengxian Decoction on doxorubicin-induced chronic heart failure model rats and a multicomponent comparative pharmacokinetic study after oral administration in normal and model rats
Cuiyun Huang et al, 2021, Biomedicine & Pharmacotherapy CrossRef - Astragaloside IV ameliorates sepsis-induced myocardial dysfunction by regulating NOX4/JNK/BAX pathway
Yi Su et al, 2022, Life Sciences CrossRef - Astragaloside IV alleviates myocardial damage induced by type 2 diabetes via improving energy metabolism
Zhen Zhang et al, 2019, Molecular Medicine Reports CrossRef - Astragaloside IV Exerts a Myocardial Protective Effect against Cardiac Hypertrophy in Rats, Partially via Activating the Nrf2/HO-1 Signaling Pathway
Pei Nie et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef - Nutritional preconditioning induced by astragaloside Ⅳ on isolated hearts and cardiomyocytes against myocardial ischemia injury via improving Bcl-2-mediated mitochondrial function
Yong Luo et al, 2019, Chemico-Biological Interactions CrossRef - Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress
Jiamao Lin et al, 2019, European Journal of Pharmacology CrossRef - Relevance of mitochondrial oxidative stress to arrhythmias: Innovative concepts to target treatments
Can Liu et al, 2022, Pharmacological Research CrossRef